Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spago | 1,319,436 | net | 21 Nov 2025 | tx 2+1,319,436 |
| Annexin Pharmaceuticals via Annexin Incentive | 480,000 | net | 04 Jun 2024 | tx 2+480,000 |
| Dicot AB | 188,000 | net | 03 Nov 2025 | tx 2+188,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Nov 2025 | PURCHASE | Spago | 624,996 | 0.08 SEK | |
| 21 Nov 2025 | PURCHASE | Spago | 694,440 | 0.00 SEK | deriv |
| 03 Nov 2025 | PURCHASE | Dicot AB | 88,000 | 0.53 SEK | |
| 03 Nov 2025 | PURCHASE | Dicot AB | 100,000 | 0.53 SEK | first after silence |
| 04 Jun 2024 | PURCHASE | Annexin Pharmaceuticals via Annexin Incentive | 240,000 | 0.25 SEK |
1 purchase reported after at least 12 months of silence — most recent on 03 Nov 2025.